15 hours Truist Financial Corp Sells 16,876 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) MarketBeat
Truist Financial Corp lowered its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 16.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 84,465 shares of the biopharmaceutical com…
Nasdaq 100 · SEC · Truist Financial Corp (TFC)